Locus Pharmaceuticals, Inc. is a world leader in fragment-based, computational drug design. We have combined highly integrated chemistry, crystallography and biology capabilities to create a unique drug design and development platform for oral drug therapies in areas of unmet need.

All of our development programs emanate from our proprietary computational technology and have been directed primarily in cancer and inflammation.

Locus has also entered into drug design/development collaborations with pharmaceutical partners based upon leveraging its broadly applicable core technology. The Locus technology has evolved as a reliable pipeline engine for new drug therapies.

Based on the success of its development programs and technology impact, Locus expects to realize clear industry distinction and competitive investor return.